Boess Carsten Insider Trades

Insider Trading History

Track insider trading activity for Boess Carsten. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Rocket Pharmaceuticals
Rocket Pharmaceuticals RCKT
Director
Holding Value $104k 30,000 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84.9k 30,000 shares
$2.83
$3.47
Avidity Biosciences
Avidity Biosciences RNA
Director
Holding Value $129k 10,034 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$337k 10,034 shares
$33.62
$12.81
Rocket Pharmaceuticals
Rocket Pharmaceuticals RCKT
Director
Holding Value $83.1k 23,944 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$547k 23,944 shares
$22.86
$3.47
Avidity Biosciences
Avidity Biosciences RNA
Director
Holding Value $173k 13,489 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$539k 13,489 shares
$39.96
$12.81
Rocket Pharmaceuticals
Rocket Pharmaceuticals RCKT
Director
Holding Value $89.7k 25,850 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$557k 25,850 shares
$21.56
$3.47
Avidity Biosciences
Avidity Biosciences RNA
Director
Holding Value $282k 22,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 22,000 shares
$12.48
$12.81
Avidity Biosciences
Avidity Biosciences RNA
Director
Holding Value $282k 22,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$265k 22,000 shares
$12.03
$12.81
Rocket Pharmaceuticals
Rocket Pharmaceuticals RCKT
Director
Holding Value $166k 47,745 shares
Last Trade
Jun 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$514k 47,745 shares
$10.77
$3.47
Avidity Biosciences
Avidity Biosciences RNA
Director
Holding Value $192k 15,000 shares
Last Trade
Jun 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$391k 15,000 shares
$26.09
$12.81
Rocket Pharmaceuticals
Rocket Pharmaceuticals RCKT
Director
Holding Value $42.5k 12,236 shares
Last Trade
Jun 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$578k 12,236 shares
$47.25
$3.47
Rocket Pharmaceuticals
Rocket Pharmaceuticals RCKT
Director
Holding Value $69.4k 20,000 shares
Last Trade
Jun 16, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$398k 20,000 shares
$19.90
$3.47
Rocket Pharmaceuticals
Rocket Pharmaceuticals RCKT
Director
Holding Value $104k 30,000 shares
Last Trade
Jan 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$437k 30,000 shares
$14.56
$3.47
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
10% owner
Holding Value $28.1M 473,035 shares
Last Trade
May 29, 2018 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.84M 107,050 shares
$17.21
$59.49
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
10% owner
Holding Value $4.73M 79,589 shares
Last Trade
May 29, 2018 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$110k 6,392 shares
$17.21
$59.49
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
10% owner
Holding Value $0 0 shares
Last Trade
May 29, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$110k 6,392 shares
$17.21
$59.49
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
10% owner
Holding Value $0 0 shares
Last Trade
May 29, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.84M 107,050 shares
$17.21
$59.49
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
10% owner
Holding Value $0 0 shares
Last Trade
May 23, 2018 Sale
No data
No data
$59.49
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
10% owner
Holding Value $0 0 shares
Last Trade
May 23, 2018 Sale
No data
No data
$59.49
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
10% owner
Holding Value $0 0 shares
Last Trade
May 23, 2018 Sale
No data
No data
$59.49
Kiniksa Pharmaceuticals International Plc.
Kiniksa Pharmaceuticals International Plc. KNSA
10% owner
Holding Value $0 0 shares
Last Trade
May 23, 2018 Sale
No data
No data
$59.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up